Overview
Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Until 2003, it was the active ingredient used in Kaopectate, before that product was reformulated with bismuth subsalicylate.
Indication
When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Attapulgite is an adsorbent.
Associated Conditions
- Acute Diarrhea
- Diarrhea
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
DIBAN CAP | wyeth-ayerst canada inc. | 02041626 | Capsule - Oral | 300 MG | 2/18/1998 |
KAOPECTATE LIQ 600MG/15ML | upjohn consumer products company | 00836656 | Liquid - Oral | 600 MG / 15 ML | 12/31/1989 |
DIARET TAB | produits francais labs inc. | 00540862 | Tablet - Oral | 350 MG / TAB | 12/31/1981 |
CHILDREN'S KAOPECTATE SUS 600MG/15ML | upjohn consumer products company | 01951165 | Suspension - Oral | 600 MG / 15 ML | 12/31/1992 |
KAOPECTATE CHEWABLE TABLETS 300MG | johnson & johnson - merck consumer pharmaceuticals of canada | 02229948 | Tablet - Oral | 300 MG | 9/18/1998 |
KAOPECTATE TABLETS 600MG | the upjohn company of canada | 00730955 | Tablet - Oral | 600 MG / TAB | 12/31/1989 |
DIBAN CAP | ayerst laboratories | 01909215 | Capsule - Oral | 300 MG | 12/31/1992 |
DIAREX TAB | nutribon (1986) inc. | 02003392 | Tablet - Oral | 350 MG / TAB | 12/31/1995 |
KAOPECTATE CHEWABLE TAB 300MG | upjohn consumer products company | 00875058 | Tablet - Oral | 300 MG | 12/31/1990 |
KAOPECTATE TABLET - 600MG | johnson & johnson - merck consumer pharmaceuticals of canada | 02229953 | Tablet - Oral | 600 MG | 7/24/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.